Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

99mTc-Human Serum Albumin: An Effective Radiotracer for Identifying Sentinel Lymph Nodes in Melanoma

Isabelle Bedrosian, Alice M. Scheff, Rosemarie Mick, Linda S. Callans, Louis P. Bucky, Francis R. Spitz, Cynthia Helsabeck, David E. Elder, Abass Alavi, Douglas F. Fraker and Brian J. Czerniecki
Journal of Nuclear Medicine July 1999, 40 (7) 1143-1148;
Isabelle Bedrosian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice M. Scheff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosemarie Mick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda S. Callans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis P. Bucky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francis R. Spitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia Helsabeck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David E. Elder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas F. Fraker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Czerniecki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 7
July 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
99mTc-Human Serum Albumin: An Effective Radiotracer for Identifying Sentinel Lymph Nodes in Melanoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
99mTc-Human Serum Albumin: An Effective Radiotracer for Identifying Sentinel Lymph Nodes in Melanoma
Isabelle Bedrosian, Alice M. Scheff, Rosemarie Mick, Linda S. Callans, Louis P. Bucky, Francis R. Spitz, Cynthia Helsabeck, David E. Elder, Abass Alavi, Douglas F. Fraker, Brian J. Czerniecki
Journal of Nuclear Medicine Jul 1999, 40 (7) 1143-1148;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
99mTc-Human Serum Albumin: An Effective Radiotracer for Identifying Sentinel Lymph Nodes in Melanoma
Isabelle Bedrosian, Alice M. Scheff, Rosemarie Mick, Linda S. Callans, Louis P. Bucky, Francis R. Spitz, Cynthia Helsabeck, David E. Elder, Abass Alavi, Douglas F. Fraker, Brian J. Czerniecki
Journal of Nuclear Medicine Jul 1999, 40 (7) 1143-1148;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Reproducibility of Lymphoscintigraphy in Cutaneous Melanoma: Can We Accurately Detect the Sentinel Lymph Node by Expanding the Tracer Injection Distance from the Tumor Site?
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire